- Home
- TNGX vs LION Comparison
TNGX vs LION Comparison
Compare TNGX & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | LION |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.4B |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | TNGX | LION |
|---|---|---|
| Price | $25.19 | $10.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $21.78 | $11.89 |
| AVG Volume (30 Days) | ★ 2.5M | 2.1M |
| Earning Date | 05-08-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $62,384,000.00 | ★ $2,631,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $6.69 | $5.88 |
| 52 Week High | $34.39 | $16.70 |
Technical Indicators
Market Signals| Indicator | TNGX | LION |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 39.80 |
| Support Level | $19.74 | $9.11 |
| Resistance Level | $26.09 | $11.02 |
| Average True Range (ATR) | 1.60 | 0.43 |
| MACD | 0.34 | 0.04 |
| Stochastic Oscillator | 80.99 | 32.03 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About LION Lionsgate Studios Corp.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.